149 related articles for article (PubMed ID: 26211819)
1. Sepsis and beta-blockade: a look into diastolic function.
Astuto M
Curr Med Res Opin; 2015; 31(10):1827-8. PubMed ID: 26211819
[TBL] [Abstract][Full Text] [Related]
2. A new frontier for an old drug? A word of caution for beta-blockers in sepsis!
Maybauer MO; Maybauer DM
Curr Med Res Opin; 2015; 31(10):1829-30. PubMed ID: 26296157
[TBL] [Abstract][Full Text] [Related]
3. Beta-blocker use in severe sepsis and septic shock: a systematic review.
Sanfilippo F; Santonocito C; Morelli A; Foex P
Curr Med Res Opin; 2015; 31(10):1817-25. PubMed ID: 26121122
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic response to β-blockers in severe sepsis and septic shock: A review of current literature.
van Loon LM; van der Hoeven JG; Lemson J
J Crit Care; 2019 Apr; 50():138-143. PubMed ID: 30540967
[TBL] [Abstract][Full Text] [Related]
5. Benefits of Beta-Blockade in Sepsis and Septic Shock: A Systematic Review.
Lee YR; Seth MS; Soney D; Dai H
Clin Drug Investig; 2019 May; 39(5):429-440. PubMed ID: 30848423
[TBL] [Abstract][Full Text] [Related]
6. Beta-blockers in septic shock: a review.
Vela-Vásquez RS; Grigorov-Tzenkov I; Aguilar JL
Rev Esp Anestesiol Reanim; 2015 Feb; 62(2):90-5. PubMed ID: 25152109
[TBL] [Abstract][Full Text] [Related]
7. [Beta-blockers in Septic Shock].
Uhlig C; Spieth PM
Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 Nov; 53(11-12):787-792. PubMed ID: 30458576
[TBL] [Abstract][Full Text] [Related]
8. Bench-to-bedside review: Beta-adrenergic modulation in sepsis.
de Montmollin E; Aboab J; Mansart A; Annane D
Crit Care; 2009; 13(5):230. PubMed ID: 19863760
[TBL] [Abstract][Full Text] [Related]
9. Misdirected Sympathy: The Role of Sympatholysis in Sepsis and Septic Shock.
Ferreira JA; Bissell BD
J Intensive Care Med; 2018 Feb; 33(2):74-86. PubMed ID: 28142307
[TBL] [Abstract][Full Text] [Related]
10. Continuing chronic beta-blockade in the acute phase of severe sepsis and septic shock is associated with decreased mortality rates up to 90 days.
Fuchs C; Wauschkuhn S; Scheer C; Vollmer M; Meissner K; Kuhn SO; Hahnenkamp K; Morelli A; Gründling M; Rehberg S
Br J Anaesth; 2017 Oct; 119(4):616-625. PubMed ID: 29121280
[TBL] [Abstract][Full Text] [Related]
11. Effect of β-blockers on mortality in patients with sepsis: A propensity-score matched analysis.
Ge CL; Zhang LN; Ai YH; Chen W; Ye ZW; Zou Y; Peng QY
Front Cell Infect Microbiol; 2023; 13():1121444. PubMed ID: 37056709
[TBL] [Abstract][Full Text] [Related]
12. Effects of Chronic Antihypertensives on Vasopressor Dosing in Septic Shock.
DeMott JM; Patel G; Lat I
Ann Pharmacother; 2018 Jan; 52(1):40-47. PubMed ID: 28799416
[TBL] [Abstract][Full Text] [Related]
13. Is It Time to Beta Block the Septic Patient?
Pemberton P; Veenith T; Snelson C; Whitehouse T
Biomed Res Int; 2015; 2015():424308. PubMed ID: 26557668
[TBL] [Abstract][Full Text] [Related]
14. Long-Term β-Blocker Therapy Decreases Blood Lactate Concentration in Severely Septic Patients.
Contenti J; Occelli C; Corraze H; Lemoël F; Levraut J
Crit Care Med; 2015 Dec; 43(12):2616-22. PubMed ID: 26427590
[TBL] [Abstract][Full Text] [Related]
15. Role of levosimendan in sepsis and septic shock.
Pinto BB; Rehberg S; Ertmer C; Westphal M
Curr Opin Anaesthesiol; 2008 Apr; 21(2):168-77. PubMed ID: 18443483
[TBL] [Abstract][Full Text] [Related]
16. The role of beta-blockers in septic patients.
Hamzaoui O; Teboul JL
Minerva Anestesiol; 2015 Mar; 81(3):312-9. PubMed ID: 24941896
[TBL] [Abstract][Full Text] [Related]
17. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
Baudo F; de Cataldo F
Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
[TBL] [Abstract][Full Text] [Related]
18. [Effects of the β-blockers on cardiac protection and hemodynamics in patients with septic shock: a prospective study].
Yang S; Liu Z; Yang W; Zhang G; Hou B; Liu J; Shi Q
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Oct; 26(10):714-7. PubMed ID: 25315942
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats.
Ackland GL; Yao ST; Rudiger A; Dyson A; Stidwill R; Poputnikov D; Singer M; Gourine AV
Crit Care Med; 2010 Feb; 38(2):388-94. PubMed ID: 19829100
[TBL] [Abstract][Full Text] [Related]
20. The use of steroids in the treatment of severe sepsis and septic shock.
Batzofin BM; Sprung CL; Weiss YG
Best Pract Res Clin Endocrinol Metab; 2011 Oct; 25(5):735-43. PubMed ID: 21925074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
